Stocks TelegraphStocks Telegraph
Stock Ideas

KPTI Financial Statements and Analysis

NASDAQ : KPTI

Karyopharm Therapeutics Inc.

$0.67
0.0524+8.46%
Open: 12:51 PM
59.36
BESG ScoreESG Rating

KPTI FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

KPTI Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue38.783M42.786M33.126M33.747M36.009M
cost of revenue1.30M1.556M1.996M1.563M911.00K
gross profit37.483M41.23M31.13M32.184M35.098M
gross profit ratio0.9660.9640.940.9540.975
research and development expenses36.134M38.28M35.34M39.304M35.553M
general and administrative expenses27.632M31.07M29.549M30.688M30.805M
selling and marketing expenses00000
selling general and administrative expenses27.632M31.07M29.549M30.688M30.805M
other expenses014.296M196.00K-211.00K89.00K
operating expenses63.766M69.35M64.889M69.992M66.358M
cost and expenses65.066M70.906M66.885M71.555M67.269M
interest income1.832M1.93M2.156M2.52M2.75M
interest expense11.385M8.949M5.884M6.208M6.073M
depreciation and amortization83.00K91.00K85.00K77.00K2.839M
ebitda-20.576M32.899M-31.322M-37.731M-28.421M
ebitda ratio-0.531-0.655-1.017-1.118-0.789
operating income-26.283M-28.12M-33.759M-37.808M-31.26M
operating income ratio-0.678-0.657-1.019-1.12-0.868
total other income expenses net-5.761M51.979M-3.532M-3.899M89.00K
income before tax-32.044M23.859M-37.291M-41.707M-34.494M
income before tax ratio-0.8260.558-1.126-1.236-0.958
income tax expense28.00K67.00K71.00K130.00K12.00K
net income-32.072M23.792M-37.362M-41.837M-34.506M
net income ratio-0.8270.556-1.128-1.24-0.958
eps-0.260.20-0.32-0.36-0.30
eps diluted-0.26-0.20-0.32-0.36-0.30
weighted average shs out125.01M121.027M115.454M114.778M114.401M
weighted average shs out dil125.01M154.425M115.454M114.778M114.401M
Graph

KPTI Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents72.828M84.806M31.087M52.891M43.655M
short term investments60.698M67.35M117.95M139.212M164.66M
cash and short term investments133.526M152.156M149.037M192.103M208.315M
net receivables31.778M37.995M31.082M26.962M37.923M
inventory4.672M3.476M2.769M3.043M3.105M
other current assets14.779M14.913M15.937M11.813M178.539M
total current assets184.755M208.54M198.366M233.921M247.164M
property plant equipment net3.081M3.799M4.454M4.882M5.482M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments306.00K304.00K304.00K301.00K381.00K
tax assets00000
other non current assets1.334M1.334M1.334M1.334M16.933M
total non current assets4.721M5.437M6.092M6.517M22.796M
other assets001.001.000
total assets189.476M213.977M204.458M240.438M269.96M
account payables5.783M2.797M5.028M3.123M943.00K
short term debt7.336M7.09M3.425M3.308M3.195M
tax payables00000
deferred revenue00-1.0000
other current liabilities48.374M47.732M56.888M63.048M57.941M
total current liabilities61.493M57.619M65.341M69.479M62.079M
long term debt190.592M192.086M173.011M170.919M170.702M
deferred revenue non current73.499M73.499M132.479M132.479M132.479M
deferred tax liabilities non current0955.00K1.884M2.789M-132.479M
other non current liabilities23.539M96.412M2.582M978.00K199.654M
total non current liabilities287.63M288.498M308.072M307.165M370.356M
other liabilities001.000-62.079M
capital lease obligations3.668M955.00K1.884M2.789M6.863M
total liabilities349.123M346.117M373.413M376.644M370.356M
preferred stock00000
common stock13.00K13.00K12.00K12.00K12.00K
retained earnings-1.533B-1.501B-1.524B-1.487B-1.445B
accumulated other comprehensive income loss-222.00K-605.00K-518.00K-161.00K-742.00K
other total stockholders equity1.373B1.369B1.356B1.351B1.346B
total stockholders equity-159.647M-132.14M-168.955M-136.206M-100.396M
total equity-159.647M-132.14M-168.955M-136.206M-100.396M
total liabilities and stockholders equity189.476M213.977M204.458M240.438M269.96M
minority interest00000
total investments61.004M67.654M118.254M139.513M164.66M
total debt194.26M195.631M176.436M177.016M170.702M
net debt121.432M110.825M145.349M124.125M127.047M
Graph

KPTI Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax0007.867M-936.00K
stock based compensation4.182M5.41M4.97M5.182M5.078M
change in working capital20.189M-9.474M-10.715M18.794M549.00K
accounts receivables6.217M-6.913M-4.12M10.961M-5.643M
inventory-1.196M-707.00K274.00K62.00K567.00K
accounts payables2.986M-2.231M1.905M2.18M-1.344M
other working capital8.397M377.00K-8.774M5.591M6.969M
other non cash items-9.723M-42.874M6.378M-8.668M205.00K
net cash provided by operating activities-19.453M-38.498M-43.725M-18.585M-29.53M
investments in property plant and equipment00-195.00K00
acquisitions net00000
purchases of investments-20.805M-4.903M-31.608M-16.56M-46.065M
sales maturities of investments28.279M56.165M53.743M43.403M38.38M
other investing activites051.262M22.135M-1.000
net cash used for investing activites7.474M51.262M21.94M26.843M-7.685M
debt repayment-40.194M-40.194M000
common stock issued6.925M772.00K0264.00K0
common stock repurchased111.00M0000
dividends paid00000
other financing activites-118.697M40.966M000
net cash used provided by financing activities040.966M0264.00K38.565M
effect of forex changes on cash36.00K-11.00K-16.00K89.00K-52.00K
net change in cash-11.639M53.719M-21.804M8.691M-37.267M
cash at end of period73.167M84.806M31.087M52.891M44.581M
cash at beginning of period84.806M31.087M52.891M44.20M81.848M
operating cashflow-19.453M-38.498M-43.725M-18.585M-29.53M
capital expenditure00-195.00K00
free cash flow-19.453M-38.498M-43.92M-18.585M-29.53M
Graph

Frequently Asked Questions

How did Karyopharm Therapeutics Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, KPTI generated $38.78M in revenue last quarter, while its costs came in at $1.30M.

Last quarter, how much Gross Profit did Karyopharm Therapeutics Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Karyopharm Therapeutics Inc. reported a $37.48M Gross Profit for the quarter ended Sep 30, 2024.

Have KPTI's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. KPTI incurred $63.77M worth of Operating Expenses, while it generated -$26.28M worth of Operating Income.

How much Net Income has KPTI posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Karyopharm Therapeutics Inc., the company generated -$32.07M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Karyopharm Therapeutics Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Karyopharm Therapeutics Inc. as of the end of the last quarter was $72.83M.

What are KPTI's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, KPTI had Total Net Receivables of $31.78M.

In terms of Total Assets and Current Assets, where did Karyopharm Therapeutics Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of KPTI were $184.76M, while the Total Assets stand at $189.48M.

As of the last quarter, how much Total Debt did Karyopharm Therapeutics Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of KPTI's debt was $194.26M at the end of the last quarter.

What were KPTI's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, KPTI reported total liabilities of $349.12M.

How much did KPTI's Working Capital change over the last quarter?

Working Capital Change for KPTI was $20.19M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

KPTI generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. KPTI generated -$19.45M of Cash from Operating Activities during its recently reported quarter.

What was KPTI's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. KPTI reported a -$11.64M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph